BL Nanobiomed at 14th International Conference & Exhibition on Green Flexible Printed Electronics Industry (ICEFPE24) and AGRIVOLTAICS 2024
We’re proud to have participated in the 14th International Conference & Exhibition on Green Flexible Printed Electronics Industry (ICEFPE24) and AGRIVOLTAICS 2024 in Athens, where BL Nanobiomed presented our latest breakthrough in early disease detection: BL NanodiagnoseTM.
About BL NanodiagnoseTM
BL Nanodiagnose is a compact, user-friendly device designed to detect cardiovascular diseases in their early stages, utilizing state-of-the-art printed biosensor technology. These biosensors are designed on flexible, green electronic materials, making the device both highly portable and sustainable. By detecting biomarkers linked to cardiovascular disease, BL NanodiagnoseTM enables healthcare providers and patients to monitor health proactively, allowing for earlier interventions and improved patient outcomes.
The Science Behind Printed Biosensors
Printed biosensors leverage advanced materials to create highly sensitive, flexible, and durable devices capable of detecting biological markers through simple and non-invasive testing. By combining innovation in material science with precise diagnostics, these devices represent a transformative shift in preventative healthcare. Our use of green, flexible electronics aligns with BL Nanobiomed’s commitment to sustainability, making BL NanodiagnoseTM a pioneering tool in both healthcare and eco-friendly technology.
The interest and support we received at ICEFPE24 and AGRIVOLTAICS 2024 underscore the potential impact of BL Nanodiagnose on healthcare. We’re excited to continue this journey, driving forward innovations in sustainable diagnostics and biosensing technology.
